Trials / Conditions / Metastatic Adenoid Cystic Carcinoma

Metastatic Adenoid Cystic Carcinoma

7 registered clinical trials studyying Metastatic Adenoid Cystic Carcinoma — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Completed	An Investigational Scan (Ga-68 PSMA-11 PET/CT) for the Detection of Therapy Response in Patients With Metastat NCT06521775	Mayo Clinic	Phase 2
Recruiting	Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic Carcinoma NCT06118086	Remix Therapeutics	Phase 1 / Phase 2
Recruiting	CB-103 With Either Lenvatinib or Abemaciclib in Patients With NOTCH ACC NCT05774899	Glenn J. Hanna	Phase 1 / Phase 2
Recruiting	Stereotactic Body Radiotherapy (SBRT) for Early Treatment of Oligometastatic Adenoid Cystic Carcinoma: The SOL NCT04883671	Dana-Farber Cancer Institute	N/A
Unknown	68Ga-FAPI PET/CT for the Detection of Adenoid Cystic Carcinoma(ACC) NCT05499936	Peking Union Medical College Hospital	N/A
Active Not Recruiting	AL101 Before Surgery for the Treatment of Notch Activated Adenoid Cystic Cancer NCT04973683	M.D. Anderson Cancer Center	Phase 1
Completed	Axitinib and Avelumab in Treating Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma NCT03990571	M.D. Anderson Cancer Center	Phase 2